Immunoregulatory effects of α-GalCer in a murine model of autoimmune myocarditis

Experimental and Molecular Pathology

Volumn 91, Issue 2, 2011, Pages 636-642

  Liu, Wei ^a   Li, Shuqing ^a   Tian, Wendan ^a   Li, Weimin ^a   Zhang, Zhiyi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Galactosylceramide; C EBP ; INKT; MMPs; Tregs

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA SMOOTH MUSCLE ACTIN; CCAAT ENHANCER BINDING PROTEIN BETA; EOSIN; GELATINASE A; GELATINASE B; HEMATOXYLIN; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CD4+ CD25+ T LYMPHOCYTE; CELL SELECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOREGULATION; MOUSE; MYOCARDITIS; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPEATED DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE; UPREGULATION; WESTERN BLOTTING;

ACTINS; ANIMALS; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; DISEASE MODELS, ANIMAL; FORKHEAD TRANSCRIPTION FACTORS; GALACTOSYLCERAMIDES; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MYOCARDITIS; MYOCARDIUM; NATURAL KILLER T-CELLS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

MURINAE; MUS; SUS;

EID: 80051491038     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2011.06.010     Document Type: Article

References (24)

1. Afanasyeva M., Georgakopoulos D., Rose N.R. Autoimmune myocarditis: cellular mediators of cardiac dysfunction. Autoimmun. Rev. 2004, 3(7-8):476-486. Review.
2. Arrenberg P., Halder R., Kumar V. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens. J. Cell. Physiol. 2009, 218:246-250.
3. Badorff C., Lee G.H., Lamphear B.J., Martone M.E., Campbell K.P., Rhoads R.E., Knowlton K.U. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 1999, 5:320-326.
4. Bai L., Sagiv Y., Liu Y., Freigang S., Yu K.O., Teyton L., Porcelli S.A., Savage P.B., Bendelac A. Lysosomal recycling terminates CD1d-mediated presentation of short and polyunsaturated variants of the NKT cell lipid antigen αGalCer. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:10254-10259.
5. Baldeviano G.C., Barin J.G., Talor M.V., Srinivasan S., Bedja D., Zheng D., Gabrielson K., Iwakura Y., Rose N.R., Cihakova D. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ. Res. 2010, 106(10):1646-1655.
6. Bobbert P., Scheibenbogen C., Jenke A., Kania G., Wilk S., Krohn S., Stehr J., Kuehl U., Rauch U., Eriksson U., Schultheiss H.P., Poller W., Skurk C. Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control. Eur. Heart J. 2011, 32(9):1134-1147.
7. Cihakova D., Rose N.R. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 2008, 99:95-114.
8. Cooper L.T. Myocarditis. N. Engl. J. Med. 2009, 360(15):1526-1538.
9. Godfrey D.I., Stankovic S., Baxter A.G. Raising the NKT cell family. Nat. Immunol. 2010, 11:197-206.
10. Hishikari K., Watanabe R., Ogawa M., Suzuki J., Masumura M., Shimizu T., Takayama K., Hirata Y., Nagai R., Isobe M. Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity. Heart 2010, 96(7):523-527.
11. Hu B., Ullenbruch M.R., Jin H., Gharaee-Kermani M., Phan S.H. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis. J. Pathol. 2007, 211(4):455-462.
12. Huang C.H., Vallejo J.G., Kollias G., Mann D.L. Role of the innate immune system in acute viral myocarditis. Basic Res. Cardiol. 2009, 104(3):228-237.
13. Huber S.A. Coxsackievirus B3-induced myocarditis: infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells. Virology 2008, 378(2):292-298.
14. Kallewaard N.L., Zhang L., Chen J.W., Guttenberg M., Sanchez M.D., Bergelson J.M. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe 2009, 23:91-98. 6(1).
15. Leuschner F., Katus H.A., Kaya Z. Autoimmune myocarditis: past, present and future. J. Autoimmun. 2009, 33(3-4):282-289.
16. + T regulatory cells in prevention of autoimmune diabetes in non-obese diabetic mice treated with alpha-galactosylceramide. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40(5):381-390.
17. Liu W., Huber S.A. Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response. Virol. J. 2011, 8. 32.g.
18. Liu W., Feng W., Wang F., Li W., Zhou B., Gao C., Li Y., Kong Y., Ma M., Fu S. Adenovirus-mediated ICOSIg gene transfer alleviates cardiac remodeling in experimental autoimmune myocarditis. Immunol. Cell Biol. 2008, 86(8):659-665.
19. Matsumoto Y., Park I.K., Kohyama K. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy. J. Immunol. 2009, 183(7):4773-4781.
20. Matsumoto Y., Park I.K., Kohyama K. Matrix metalloproteinase (MMP)-9, but not MMP-2, is involved in the development and progression of C protein-induced myocarditis and subsequent dilated cardiomyopathy. J. Immunol. 2009, 183(7):4773-4781.
21. Shi Y., Chen C., Lisewski U., Wrackmeyer U., Radke M., Westermann D., Sauter M., Tschöpe C., Poller W., Klingel K., Gotthardt M. Cardiac deletion of the coxsackievirus-adenovirus receptor abolishes coxsackievirus B3 infection and prevents myocarditis in vivo. J. Am. Coll. Cardiol. 2009, 53:1219-1226.
22. Wakisaka Y., Niwano S., Niwano H., Saito J., Yoshida T., Hirasawa S., Kawada H., Izumi T. Structural and electrical ventricular remodeling in rat acute myocarditis and subsequent heart failure. Cardiovasc. Res. 2004, 63(4):689-699.
23. Watanabe K., Sukumaran V., Veeraveedu P.T., Thandavarayan R.A., Gurusamy N., Ma M., Arozal W., Sari F.R., Lakshmanan A.P., Arumugam S., Soetikno V., Rajavel V., Suzuki K. Regulation of inflammation and myocardial fibrosis in experimental autoimmune myocarditis. Inflamm. Allergy Drug Targets 2011, 10(3):218-225.
24. Xiong D., Yajima T., Lim B.K., Stenbit A., Dublin A., Dalton N.D., Summers-Torres D., Molkentin J.D., Duplain H., Wessely R., Chen J., Knowlton K.U. Inducible cardiac-restricted expression of enteroviral protease 2A is sufficient to induce dilated cardiomyopathy. Circulation 2007, 115:94-102.